As of May 2022 Dynavax Technologies has a market cap of $1.24 Billion. This makes Dynavax Technologies the world's 4041th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.21 B | -28.15% |
2021 | $1.68 B | 244.19% |
2020 | $0.49 B | 2.21% |
2019 | $0.47 B | -16.59% |
2018 | $0.57 B | -49.24% |
2017 | $1.13 B | 644.59% |
2016 | $0.15 B | -83.62% |
2015 | $0.92 B | 109.42% |
2014 | $0.44 B | -13.89% |
2013 | $0.51 B | -1.13% |
2012 | $0.52 B | 23.74% |
2011 | $0.42 B | 13.8% |
2010 | $0.36 B | 379.99% |
2009 | $0.07 B | 130.23% |
2008 | $0.03 B | -83.52% |
2007 | $0.20 B | -44.27% |
2006 | $0.36 B | 265.8% |
2005 | $0.09 B | -47.38% |
2004 | $0.18 B |
On May 16th, 2022 the market cap of Dynavax Technologies was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $284.30 B | 22,820.67% | ๐บ๐ธ USA |
![]() Amgen AMGN | $130.27 B | 10,402.83% | ๐บ๐ธ USA |
![]() Biogen BIIB | $29.05 B | 2,242.27% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $78.06 B | 6,193.88% | ๐บ๐ธ USA |
![]() Merck MRK | $233.45 B | 18,721.57% | ๐บ๐ธ USA |
![]() Astrazeneca AZN | $199.84 B | 16,011.95% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $112.78 B | 8,993.00% | ๐ฌ๐ง UK |
![]() Agenus
AGEN | $0.42 B | -65.48% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $8.78 B | 608.08% | ๐ฎ๐ฑ Israel |